Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Renovo presents 12-month data for Juvista in varicose vein surgery

June 10, 2009

Peplin initiates phase III trials of PEP-005 in face and scalp actinic keratoses

June 10, 2009

Can-Fite completes patient enrollment in phase II trial of CF-101 in psoriasis

June 3, 2009

FDA extends review timeline for Centocor's BLA for Stelara for plaque psoriasis

May 29, 2009

Pregabalin may improve uremic pruritus in hemodialysis patients

May 28, 2009

Astellas launches Protopic in Europe in a new twice-weekly regimen

May 26, 2009

Peplin presents results for phase III PEP-005 trial in actinic keratosis

May 19, 2009

Novel cathepsin inhibitor VBY-129 developed by Virobay for the treatment of autoimmune diseases

May 19, 2009

Boehringer Ingelheim reports discovery of chemokine CCR10 receptor antagonists as antipsoriatics

May 18, 2009

NIAID awards Dynavax 2-year grant for TLR inhibitors in skin diseases

May 14, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....